It would modernize FDA regulations, raise awareness of research that includes pregnant and lactating women, and encourage high-quality priority research projects to be conducted at the NIH
Raise awareness of research that includes pregnant and lactating women.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
Rep. Kathy Castor introduced H.R. 8651 on May 4, 2026. Section 3 would require HHS to establish an education campaign on including pregnant and lactating women in clinical research, available trials and registries, and enrollment. The bill was introduced and referred to Energy and Commerce, not enacted in the record reviewed.
legacy_unverified · Source version not recorded · locator unknown
Castor's office announced she reintroduced H.R. 8651, saying it would modernize FDA regulations, raise awareness of research that includes pregnant and lactating women, and encourage NIH priority research projects.
Assessments
Castor materially advanced the issue by introducing H.R. 8651 in the 119th Congress, including a provision for an HHS education campaign on including pregnant and lactating women in clinical research. However, the bill remains introduced/referred to committee and the promised awareness campaign or comparable federal policy outcome has not been enacted or implemented. This is a serious legislative attempt without delivery.